139 related articles for article (PubMed ID: 36706537)
1. Generation of feeder-independent transgene-free iPSC lines from a young-onset Parkinson's disease (YOPD) patient with a homozygous PLA2G6: c.2222G>A (p. Arg741Gln) mutation (NCBSi003-A) and unaffected heterozygous parent (NCBSi004-A).
Gopurappilly R; Musthafa T; Sukumaran S; Viswanath B; Hasan G
Stem Cell Res; 2023 Mar; 67():103033. PubMed ID: 36706537
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line LNDWCHi001-A from a patient with early-onset Parkinson's disease carrying the homozygous c.1898C > T (p. A633V) mutation in the PLA2G6 gene.
Huang J; Jiang Q; Pang D; Yu Y; Cui Y; Li C; Shang H
Stem Cell Res; 2024 Mar; 75():103305. PubMed ID: 38215561
[TBL] [Abstract][Full Text] [Related]
3. PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease.
Lu CS; Lai SC; Wu RM; Weng YH; Huang CL; Chen RS; Chang HC; Wu-Chou YH; Yeh TH
Am J Med Genet B Neuropsychiatr Genet; 2012 Mar; 159B(2):183-91. PubMed ID: 22213678
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.
Chiu CC; Wang HL; Weng YH; Chen RS; Chen CM; Yeh TH; Lu CS; Chen YJ; Liu YC; Huang YZ; Chang KH
Stem Cell Res; 2019 Oct; 40():101552. PubMed ID: 31493761
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
[TBL] [Abstract][Full Text] [Related]
6. Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review.
Chu YT; Lin HY; Chen PL; Lin CH
BMC Neurol; 2020 Mar; 20(1):101. PubMed ID: 32183746
[TBL] [Abstract][Full Text] [Related]
7. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
[TBL] [Abstract][Full Text] [Related]
8. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent Stem Cell Derived Neurons as In Vitro Models for Studying Autosomal Recessive Parkinson's Disease (ARPD): PLA2G6 and Other Gene Loci.
Gopurappilly R
Adv Exp Med Biol; 2021; 1347():115-133. PubMed ID: 33990932
[TBL] [Abstract][Full Text] [Related]
10. PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
Miki Y; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K
Neurosci Lett; 2017 Apr; 645():40-45. PubMed ID: 28213071
[TBL] [Abstract][Full Text] [Related]
11. Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.
Gui YX; Xu ZP; Wen-Lv ; Liu HM; Zhao JJ; Hu XY
Parkinsonism Relat Disord; 2013 Jan; 19(1):21-6. PubMed ID: 23182313
[TBL] [Abstract][Full Text] [Related]
12. Homozygous PLA2G6 (PARK 14) gene mutation associated neuropsychiatric phenotypes from southern India.
Sakhardande KA; Reddi VSK; Mishra S; Navin K; Ramu A; Arunachal G; Mangalore S; Yadav R; Jain S
Parkinsonism Relat Disord; 2021 Sep; 90():49-51. PubMed ID: 34365112
[TBL] [Abstract][Full Text] [Related]
13. PLA2G6 variant in Parkinson's disease.
Tomiyama H; Yoshino H; Ogaki K; Li L; Yamashita C; Li Y; Funayama M; Sasaki R; Kokubo Y; Kuzuhara S; Hattori N
J Hum Genet; 2011 May; 56(5):401-3. PubMed ID: 21368765
[TBL] [Abstract][Full Text] [Related]
14. Association of rare heterozygous PLA2G6 variants with the risk of Parkinson's disease.
Liu H; Wang Y; Pan H; Xu K; Jiang L; Zhao Y; Xu Q; Sun Q; Tan J; Yan X; Li J; Tang B; Guo J
Neurobiol Aging; 2021 May; 101():297.e5-297.e8. PubMed ID: 33279242
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation.
Li L; Si X; Lei M; Yang J; Ruan J; Liu H; Huang F; Jin X; Xie K; Yang H; Lei X; Liu Y
Stem Cell Res; 2023 Feb; 66():102983. PubMed ID: 36469984
[TBL] [Abstract][Full Text] [Related]
16. PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort.
Shi CH; Tang BS; Wang L; Lv ZY; Wang J; Luo LZ; Shen L; Jiang H; Yan XX; Pan Q; Xia K; Guo JF
Neurology; 2011 Jul; 77(1):75-81. PubMed ID: 21700586
[TBL] [Abstract][Full Text] [Related]
17. Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration.
Xie F; Cen Z; Ouyang Z; Wu S; Xiao J; Luo W
Parkinsonism Relat Disord; 2015 Apr; 21(4):420-2. PubMed ID: 25660576
[No Abstract] [Full Text] [Related]
18. PLA2G6-associated late-onset parkinsonism in a Sudanese family.
Bakhit Y; Tesson C; Ibrahim MO; Eltom K; Eltazi I; Elsayed LEO; Lesage S; Seidi O; Corvol JC; Wüllner U;
Ann Clin Transl Neurol; 2023 Jun; 10(6):983-989. PubMed ID: 37139542
[TBL] [Abstract][Full Text] [Related]
19. PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan.
Daida K; Nishioka K; Li Y; Yoshino H; Shimada T; Dougu N; Nakatsuji Y; Ohara S; Hashimoto T; Okiyama R; Yokochi F; Suzuki C; Tomiyama M; Kimura K; Ueda N; Tanaka F; Yamada H; Fujioka S; Tsuboi Y; Uozumi T; Takei T; Matsuzaki S; Shibasaki M; Kashihara K; Kurisaki R; Yamashita T; Fujita N; Hirata Y; Ii Y; Wada C; Eura N; Sugie K; Higuchi Y; Kojima F; Imai H; Noda K; Shimo Y; Funayama M; Hattori N
Neurobiol Aging; 2021 Jan; 97():147.e1-147.e9. PubMed ID: 32771225
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism.
Yoshino H; Tomiyama H; Tachibana N; Ogaki K; Li Y; Funayama M; Hashimoto T; Takashima S; Hattori N
Neurology; 2010 Oct; 75(15):1356-61. PubMed ID: 20938027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
